Addition of atezolizumab to capecitabine + bevacizumab is not clinically beneficial in the treatment of refractory metastatic colorectal cancer | 2 Minute Medicine
2 Minute Medicine ,
1. Atezolizumab plus capecitabine + bevacizumab performed marginally better with regards to progression free survival in…